Skip to main content
. 2023 Jun 4;30(6):5456–5469. doi: 10.3390/curroncol30060413

Table 3.

Drug-related toxicities.

T/R R/T T R
N % N % p-Value N % N % p-Value
All events G3/G4 N = 582 155 26.6 132 22.6 - 160 27.4 135 23.1 -
All pts who experienced
G3/G4 toxicities N = 390
89/146 60.9 (22.8) 79/116 68.1 (20.2) 0.24 118/325 36.3 (30.2) 104/279 37.2 (26.6) 0.86
All Haematologic events
G3/G4 N = 289
87 56.1 (14.9) 65 49.2 (11.1) 0.28 126 78.7 (21.6) 11 8.1 (1.8) <0.00001
All non Haematologic events G3/G4 N=293 68 43.8 (11.6) 67 50.7 (11.5) 34 21.2 (5.8) 124 91.8 (21.3)
Most common Haematologic
toxicities G3/G4
   Neutropenia 68 78.2 43 66.2 0.13 82 65.1 3 27.3 0.02
   Leucopenia 2 2.3 0 0 0.5 6 4.8 0 0 1
   Thrombocytopenia 3 3.4 5 7.7 0.28 3 2.4 0 0 1
   Anemia 14 16.1 17 26.2 0.15 35 27.8 8 72.7 0.0042
Most common non Haematologic toxicities G3/G4
   Fatigue 33 48.5 19 28.4 0.02 21 61.8 34 27.4 0.0004
   Hand-foot skin reaction 5 7.4 25 37.3 0.01 0 0 42 33.9 0.01
   Liver dysfunctions 2 2.9 2 3 1 2 5.9 1 0.8 0.11
   Diarrhea 10 14.7 2 3 0.03 7 20.6 13 10.5 1.14
   Skin disorders 2 2.9 3 4.5 1 0 0 11 8.9 0.12
   Others 16 23.5 16 23.9 1 4 11.8 23 18.5 0.44

Abbreviations: T, trifluridine/tipiracil; R, regorafenib.